US2005130940A1PendingUtilityA1
Triazole derivatives useful in therapy
Est. expiryFeb 2, 2016(expired)· nominal 20-yr term from priority
A61P 31/10A61P 31/00A61P 17/00Y02P20/55C07F 9/65583C07F 9/6518
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides compounds of formula I, R 1 —OP(O)(OH) 2 I wherein R 1 represents the non-hydroxy portion of a triazole antifungal compound of the type comprising a tertiary hydroxy group; or a pharmaceutically acceptable salt thereof. The compounds of the invention are useful in the treatment of fungal infections, and have good aqueous solubility.
Claims
exact text as granted — not AI-modified1 . A compound of formula I,
R 1 —OP(O)(OH) 2 I wherein R 1 represents the non-hydroxy portion of a triazole antifungal compound of the type comprising a tertiary hydroxy group; or a pharmaceutically acceptable salt thereof.
2 . A compound as claimed in claim 1 , wherein R 1 is a group of formula Ia,
in which
R 2 represents phenyl substituted by one or more halogen atoms;
R 3 represents H or CH 3 ;
R 3a represents H, or together with R 3 it may represent ═CH 2 ; and
R 4 represents a 5- or 6-membered nitrogen-containing heterocyclic ring which is optionally substituted by one or more groups selected from halogen, ═O, phenyl [substituted by a group selected from CN and (C 6 H 4 )—OCH 2 CF 2 CHF 2 ] or CH═CH—(C 6 H 4 )—OCH 2 CF 2 CHF 2 CHF 2 ; or phenyl substituted by one or more groups selected from halogen and methylpyrazolyl.
3 . A compound as claimed in claim 2 , wherein R 2 is 2,4-difluorophenyl.
4 . A compound as claimed in claim 3 , wherein R 3 is H or methyl.
5 . A compound as claimed in claims 4 , wherein R 4 represents or comprises a triazolyl, pyrimidinyl or thiazolyl group.
6 - 14 (Canceled)Join the waitlist — get patent alerts
Track US2005130940A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.